Segmented information |
12 Months Ended |
---|---|
Dec. 31, 2022 | |
Segmented information | |
Segmented information |
19.Segmented information The Company operates in one reportable operating segment, being the development and commercialization of therapies to treat progressive kidney disease. As the operations comprise a single reporting segment, amounts disclosed also represent segment amounts. All long-term assets of the Company are located in Canada. |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The disclosure of operating segments. [Refer: Operating segments [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|